Form 4: MaxCyte Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Ali Soleymannezhad, Chief Commercial Officer of MaxCyte, Inc., sold 1,211 shares of common stock on March 18, 2025, to cover tax withholding obligations related to vested restricted stock units.
Summary
- On March 18, 2025, Ali Soleymannezhad, the Chief Commercial Officer of MaxCyte, Inc., sold 1,211 shares of common stock.
- The sale was executed to cover tax withholding requirements associated with the vesting of previously granted restricted stock units (RSUs).
- The shares were sold at a weighted average price of $3.1793.
- Following the transaction, Soleymannezhad directly owns 59,439 shares of MaxCyte common stock.
Sentiment
Score: 5
Explanation: Neutral. This is a standard transaction for covering tax obligations related to stock-based compensation.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 03/18/2025 | Date of stock sale transaction |
| 03/20/2025 | Date of signature on the Form 4 filing |
Keywords
MaxCyte, MXCT, Ali Soleymannezhad, Chief Commercial Officer, stock sale, Form 4, restricted stock units, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.